Pancreatic Cancer Research

ResearcherSouthern Medical UniversityActive in the last 2 years

Shulong Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7466-4366; OpenAlex author ID A5102926748. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
9
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 3

  1. A multi-scale fusion model based on multi-phase contrast-enhanced CT for predicting pancreatic cancer resectability. Last author DOI 10.1088/1361-6560/ae98dd↗
  2. Computed tomography and guidelines-based human-machine fusion model for predicting resectability of the pancreatic cancer. Co-author DOI 10.1111/jgh.16401↗
  3. A multimodal model fusing multiphase contrast-enhanced CT and clinical characteristics for predicting lymph node metastases of pancreatic cancer. Last author DOI 10.1088/1361-6560/ac858e↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yi Gao · 3 shared papers, 2022–2026 · strength 0.69
  2. Xiaohui Cheng · 1 shared paper, 2026 · strength 0.33
  3. Lei Feng · 1 shared paper, 2024 · strength 0.22
  4. Chenjie Zhou · 1 shared paper, 2024 · strength 0.22
  5. Adilijiang Yimamu · 1 shared paper, 2024 · strength 0.22
  6. Xiaowu Xu · 1 shared paper, 2022 · strength 0.14
  7. Xuemin Chen · 1 shared paper, 2022 · strength 0.14
  8. Qian Lu · 1 shared paper, 2022 · strength 0.14
  9. Chenjie Zhou · 1 shared paper, 2022 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.